BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 35986378)

  • 21. Establishment and application of a novel patient-derived KIAA1549:BRAF-driven pediatric pilocytic astrocytoma model for preclinical drug testing.
    Selt F; Hohloch J; Hielscher T; Sahm F; Capper D; Korshunov A; Usta D; Brabetz S; Ridinger J; Ecker J; Oehme I; Gronych J; Marquardt V; Pauck D; Bächli H; Stiles CD; von Deimling A; Remke M; Schuhmann MU; Pfister SM; Brummer T; Jones DT; Witt O; Milde T
    Oncotarget; 2017 Feb; 8(7):11460-11479. PubMed ID: 28002790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment during a developmental window prevents NF1-associated optic pathway gliomas by targeting Erk-dependent migrating glial progenitors.
    Jecrois ES; Zheng W; Bornhorst M; Li Y; Treisman DM; Muguyo D; Huynh S; Andrew SF; Wang Y; Jiang J; Pierce BR; Mao H; Krause MK; Friend A; Nadal-Nicolas F; Stasheff SF; Li W; Zong H; Packer RJ; Zhu Y
    Dev Cell; 2021 Oct; 56(20):2871-2885.e6. PubMed ID: 34428430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Midkine activation of CD8
    Guo X; Pan Y; Xiong M; Sanapala S; Anastasaki C; Cobb O; Dahiya S; Gutmann DH
    Nat Commun; 2020 May; 11(1):2177. PubMed ID: 32358581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pediatric low-grade gliomas and the need for new options for therapy: Why and how?
    Qaddoumi I; Sultan I; Broniscer A
    Cancer Biol Ther; 2009 Jan; 8(1):4-10. PubMed ID: 19164945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reimagining pilocytic astrocytomas in the context of pediatric low-grade gliomas.
    Milde T; Rodriguez FJ; Barnholtz-Sloan JS; Patil N; Eberhart CG; Gutmann DH
    Neuro Oncol; 2021 Oct; 23(10):1634-1646. PubMed ID: 34131743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BRAF activation induces transformation and then senescence in human neural stem cells: a pilocytic astrocytoma model.
    Raabe EH; Lim KS; Kim JM; Meeker A; Mao XG; Nikkhah G; Maciaczyk J; Kahlert U; Jain D; Bar E; Cohen KJ; Eberhart CG
    Clin Cancer Res; 2011 Jun; 17(11):3590-9. PubMed ID: 21636552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phospholipase Cγ1 (PLCG1) overexpression is associated with tumor growth and poor survival in IDH wild-type lower-grade gliomas in adult patients.
    Li T; Yang Z; Li H; Zhu J; Wang Y; Tang Q; Shi Z
    Lab Invest; 2022 Feb; 102(2):143-153. PubMed ID: 34697421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [CDK1 expression and effects of CDK1 silencing on the malignant phenotype of glioma cells].
    Chen H; Huang Q; Zhai DZ; Dong J; Wang AD; Lan Q
    Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):484-8. PubMed ID: 18069625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNA sequence analysis reveals ITGAL/CD11A as a stromal regulator of murine low-grade glioma growth.
    De Andrade Costa A; Chatterjee J; Cobb O; Sanapala S; Scheaffer S; Guo X; Dahiya S; Gutmann DH
    Neuro Oncol; 2022 Jan; 24(1):14-26. PubMed ID: 34043012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pediatric low-grade gliomas: implications of the biologic era.
    Packer RJ; Pfister S; Bouffet E; Avery R; Bandopadhayay P; Bornhorst M; Bowers DC; Ellison D; Fangusaro J; Foreman N; Fouladi M; Gajjar A; Haas-Kogan D; Hawkins C; Ho CY; Hwang E; Jabado N; Kilburn LB; Lassaletta A; Ligon KL; Massimino M; Meeteren SV; Mueller S; Nicolaides T; Perilongo G; Tabori U; Vezina G; Warren K; Witt O; Zhu Y; Jones DT; Kieran M
    Neuro Oncol; 2017 Jun; 19(6):750-761. PubMed ID: 27683733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. "Footprint-free" human induced pluripotent stem cell-derived astrocytes for in vivo cell-based therapy.
    Mormone E; D'Sousa S; Alexeeva V; Bederson MM; Germano IM
    Stem Cells Dev; 2014 Nov; 23(21):2626-36. PubMed ID: 24914471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High frequency of disease progression in pediatric spinal cord low-grade glioma (LGG): management strategies and results from the German LGG study group.
    Perwein T; Benesch M; Kandels D; Pietsch T; Schmidt R; Quehenberger F; Bison B; Warmuth-Metz M; Timmermann B; Krauss J; Thomale UW; Kortmann RD; Driever PH; Gnekow AK
    Neuro Oncol; 2021 Jul; 23(7):1148-1162. PubMed ID: 33346834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular alterations in the integrated diagnosis of pediatric glial and glioneuronal tumors: A single center experience.
    Colli SL; Cardoso N; Massone CA; Cores M; García Lombardi M; De Matteo EN; Lorenzetti MA; Preciado MV
    PLoS One; 2022; 17(4):e0266466. PubMed ID: 35363819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Duplications of KIAA1549 and BRAF screening by Droplet Digital PCR from formalin-fixed paraffin-embedded DNA is an accurate alternative for KIAA1549-BRAF fusion detection in pilocytic astrocytomas.
    Appay R; Fina F; Macagno N; Padovani L; Colin C; Barets D; Ordioni J; Scavarda D; Giangaspero F; Badiali M; Korshunov A; M Pfister S; T W Jones D; Figarella-Branger D
    Mod Pathol; 2018 Oct; 31(10):1490-1501. PubMed ID: 29802359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rare adult pilocytic astrocytoma of the septum pellucidum with novel RIN2::BRAF fusion.
    Liu X; Dai X; Dai C; Zhu Q; Chen A; Chen Y; Chen N; Chen P; Rong R; Shi C; Xiao S; Dong J
    Virchows Arch; 2023 Feb; 482(2):445-450. PubMed ID: 36520196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic impact of distinct genetic entities in pediatric diffuse glioma WHO-grade II-Report from the German/Swiss SIOP-LGG 2004 cohort.
    Falkenstein F; Gessi M; Kandels D; Ng HK; Schmidt R; Warmuth-Metz M; Bison B; Krauss J; Kortmann RD; Timmermann B; Thomale UW; Albert MH; Pekrun A; Maaß E; Gnekow AK; Pietsch T
    Int J Cancer; 2020 Oct; 147(8):2159-2175. PubMed ID: 32239677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrated genomic analysis reveals actionable targets in pediatric spinal cord low-grade gliomas.
    Misove A; Vicha A; Broz P; Vanova K; Sumerauer D; Stolova L; Sramkova L; Koblizek M; Zamecnik J; Kyncl M; Holubova Z; Liby P; Taborsky J; Benes V; Pernikova I; Jones DTW; Sill M; Stancokova T; Krskova L; Zapotocky M
    Acta Neuropathol Commun; 2022 Sep; 10(1):143. PubMed ID: 36163281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Challenges in Drug Discovery for Neurofibromatosis Type 1-Associated Low-Grade Glioma.
    Ricker CA; Pan Y; Gutmann DH; Keller C
    Front Oncol; 2016; 6():259. PubMed ID: 28066715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequent FGFR1 hotspot alterations in driver-unknown low-grade glioma and mixed neuronal-glial tumors.
    Engelhardt S; Behling F; Beschorner R; Eckert F; Kohlhof P; Tatagiba M; Tabatabai G; Schuhmann MU; Ebinger M; Schittenhelm J
    J Cancer Res Clin Oncol; 2022 Apr; 148(4):857-866. PubMed ID: 35018490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MR Imaging Characteristics and ADC Histogram Metrics for Differentiating Molecular Subgroups of Pediatric Low-Grade Gliomas.
    Shrot S; Kerpel A; Belenky J; Lurye M; Hoffmann C; Yalon M
    AJNR Am J Neuroradiol; 2022 Sep; 43(9):1356-1362. PubMed ID: 36007944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.